# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA3738667 | ADME | Cytotoxicity against human MT4 cells assessed as reduction in cell proliferation after 96 hrs by MTT assay | Homo sapiens | 28 | ALA3734708 | cell-based format | Scientific Literature | |
2. | ALA3738668 | Functional | Antiviral activity against HIV-1 3B infected in human MT4 cells assessed as protection against virus-induced cytopathic effect after 4 days by MTT assay | Human immunodeficiency virus 1 | 28 | ALA3734708 | organism-based format | Scientific Literature | |
3. | ALA3738669 | ADME | Cytotoxicity against MDBK cells assessed as reduction in cell viability after 72 hrs by MTT assay | Bos taurus | 28 | ALA3734708 | cell-based format | Scientific Literature | |
4. | ALA3738670 | Functional | Antiviral activity against BVDV NADL ATCC VR-534 infected in MDBK cells assessed as protection against virus-induced cytopathic effect after 3 or 4 days by MTT assay | Bovine viral diarrhea virus 1 | 27 | ALA3734708 | organism-based format | Scientific Literature | |
5. | ALA3738671 | ADME | Cytotoxicity against BHK21 cells assessed as reduction in cell viability after 72 hrs by MTT assay | Mesocricetus auratus | 28 | ALA3734708 | cell-based format | Scientific Literature | |
6. | ALA3738672 | Functional | Antiviral activity against YFV 17-D vaccine (Stamaril Pasteur J07B01) infected in BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 or 4 days by MTT assay | Yellow fever virus | 28 | ALA3734708 | organism-based format | Scientific Literature | |
7. | ALA3738673 | Functional | Antiviral activity against Reovirus 1 ATCC VR- 214 infected in BHK21 cells assessed as protection against virus-induced cytopathic effect after 3 or 4 days by MTT assay | Mammalian orthoreovirus 1 | 29 | ALA3734708 | cell-based format | Scientific Literature | |
8. | ALA3738674 | ADME | Cytotoxicity against african green monkey Vero 76 cells assessed as reduction in cell viability after 48 to 96 hrs by MTT assay | Chlorocebus sabaeus | 28 | ALA3734708 | cell-based format | Scientific Literature | |
9. | ALA3738675 | Functional | Antiviral activity against CVB-5 virus Faulkner ATCC VR-185 infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay | Coxsackievirus B5 | 31 | ALA3734708 | organism-based format | Scientific Literature | |
10. | ALA3738676 | Functional | Antiviral activity against Human poliovirus 1 strain Sabin 1 virus infected in african green monkey Vero-76 cells after 2 days by plaque reduction assay | Human poliovirus 1 strain Sabin | 28 | ALA3734708 | organism-based format | Scientific Literature | |
11. | ALA3738677 | Functional | Antiviral activity against RSVA2 ATCC VR-1540 infected in african green monkey Vero-76 cells after 5 days by plaque reduction assay | Respiratory syncytial virus | 28 | ALA3734708 | organism-based format | Scientific Literature | |
12. | ALA3738678 | Functional | Antiviral activity against VSV Indiana ATCC VR-158 infected in african green monkey Vero-76 cells after 2 days by plaque reduction assay | Vesicular stomatitis virus | 28 | ALA3734708 | organism-based format | Scientific Literature | |
13. | ALA3738679 | Functional | Antiviral activity against VV Elstree ATCC VR-1549 infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay | Vaccinia virus | 28 | ALA3734708 | organism-based format | Scientific Literature | |
14. | ALA3738680 | Functional | Antiviral activity against HSV-1 KOS ATCC VR- 1493 infected in african green monkey Vero-76 cells after 3 days by plaque reduction assay | Human alphaherpesvirus 1 | 28 | ALA3734708 | organism-based format | Scientific Literature |